Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer

Figure 3

Prognosis signature. (a) The overview of the prognosis model; (b) KM survival curve of high- and low-risk patients; (c–e) the ROC curve of 1-, 3-, and 5-year survival; (f–k) clinical correlation of model gene methylation and risk score.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)